Relapse-Prevention Booklets as an Adjunct to a Tobacco Telephone Helpline("Quitline")
- Conditions
- Smoking Cessation
- Interventions
- Behavioral: Smoking Cessation
- Registration Number
- NCT01352000
- Brief Summary
The study primary purpose is smoking relapse prevention. This study is a collaboration between researchers who developed the relapse-prevention intervention, at the H. Lee Moffitt Cancer Center in Tampa, Florida, and those associated with the "New York State Smokers' Quitline" (NYSSQL), at Roswell Park Cancer Institute in Buffalo, New York.
- Detailed Description
In this study, approximately 3400 quitline clients will be randomized to one of three conditions at the point of their 2-week follow-up call. One-third will be randomized to a Usual Care (UC) condition, which will receive regular quitline services. One-third will be randomized to a Repeated Mailings (RM) condition, which will receive the 8 Forever Free booklets sent by mail at regular intervals over a period of 12 months. And one-third will be randomized to a Massed Mailings (MM) condition, which will receive all 8 booklets in a single mailing.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 3830
- referrals from the New York State Smokers' Quitline
- at least 18 years of age
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Repeated Mailings (RM) Smoking Cessation Receive the 8 Forever Free booklets sent by mail at regular intervals over a period of 12 months Massed Mailings (MM) Smoking Cessation Receive all 8 booklets in a single mailing Usual Care (UC) Smoking Cessation Receive Quitline services
- Primary Outcome Measures
Name Time Method 7-Day Point-Prevalence Abstinence at Each Follow-up Point 24 months To test the effectiveness of a self-help, relapse-prevention intervention (Forever Free booklets) as an adjunct to a state telephone quitline
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
H. Lee Moffitt Cancer Center and Research Institute
🇺🇸Tampa, Florida, United States